Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
knDbBvMr9N3eLR3n
